Related Experiment Video
Updated: Jul 20, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and
Pierre Couppié1, Christine Aznar, Bernard Carme
1Service de Dermatologie, French Guiana, Centre Hospitalier de Cayenne, Centre Hospitalier de Cayenne, Cayenne, French Guiana. couppie.pierre@voila.fr
Purpose Of Review:
Histoplasmosis due to Histoplasma capsulatum var capsulatum is a frequent systemic fungal infection in the Americas. Diagnostic and therapeutic options differ between North and South America. Disseminated histoplasmosis is an AIDS-defining infection. Prognostic factors of potentially severe presentations must be evaluated in order to facilitate the initial therapeutic choice.
Recent Findings:
Patients with HIV with disseminated infections presenting with severe pulmonary and renal impairment have a poor prognosis. Cutaneous presentations are more frequent in HIV patients in South America than in North America. A murine model has shown that South American isolates have a greater virulence that North American isolates. These differences are due in part to diagnostic delays in resource-poor countries.
Summary:
Direct examination of May-Grünwald-Giemsa-stained smears or tissues in suspected histoplasmosis is a simple means of confirming the diagnosis in resource-poor settings. Studies of prognostic factors should further refine indication criteria to guide first-line treatment choice between amphotericin B and itraconazole. The association of tuberculosis and histoplasmosis is frequent in HIV patients and presents diagnostic and therapeutic challenges that may be difficult to resolve in resource-poor settings. It is important that affordable generic drugs for treating histoplasmosis be made widely available in resource-poor countries.
Insights
Histoplasmosis diagnosis and treatment vary across the Americas, especially in HIV patients. Early diagnosis and accessible treatments are crucial for managing this systemic fungal infection, particularly in resource-limited settings.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Histoplasmosis, caused by Histoplasma capsulatum var capsulatum, is a common systemic fungal infection in the Americas.
- Diagnostic and therapeutic approaches for histoplasmosis differ between North and South America.
- Disseminated histoplasmosis is an AIDS-defining illness, necessitating evaluation of prognostic factors for severe cases.
Purpose of the Study:
- To evaluate prognostic factors for severe histoplasmosis presentations to guide initial therapeutic choices.
- To highlight regional differences in histoplasmosis diagnosis and treatment between North and South America.
- To address the challenges of diagnosing and treating co-infections like tuberculosis and histoplasmosis in HIV patients, especially in resource-poor settings.
Main Methods:
- Review of diagnostic and therapeutic options for histoplasmosis.
- Analysis of prognostic factors in patients with disseminated infections, particularly those with HIV.
- Comparison of clinical presentations and isolate virulence between North and South American strains.
Main Results:
- Patients with HIV and disseminated histoplasmosis with severe pulmonary and renal impairment have a poor prognosis.
- Cutaneous presentations are more common in HIV patients in South America, where isolates show greater virulence compared to North American strains.
- Diagnostic delays in resource-poor countries contribute to disparities in outcomes.
Conclusions:
- Direct examination of stained smears is a simple diagnostic method in resource-limited settings.
- Further studies on prognostic factors are needed to guide the choice between amphotericin B and itraconazole.
- Accessible generic medications and improved diagnostic/therapeutic strategies are vital for resource-poor countries, especially for co-infections like tuberculosis and histoplasmosis in HIV patients.
Related Concept Videos
Cryptococcal Meningitis
Toxoplasmosis
American Trypanosomiasis
Amebiasis
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
